http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0613315-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b6121dedd894b3f760906b68697d616 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5578 |
filingDate | 2006-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_511e30858f60234904149dbef873079d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce584565f23f4d6f6568c3b374d9e49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0ebf9b79ba1d20aad9b0272d341675 |
publicationDate | 2009-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0613315-A2 |
titleOfInvention | uses of prostacyclin analogs |
abstract | USES OF PROSTACYCLINE ANALOGS. Where the present invention provides a method for reducing the risk of developing cancer in a subject. This method is particularly useful in a subject who has a higher risk factor for developing cancer compared to a person who does not have a similar risk factor. The method encompasses the therapeutic administration of an effective amount of prostacyclin analogs to the subject. In this way, a variety of cancers including, but not limited to, lung, liver, brain, pancreatic, kidney, prostate, breast, bladder, ovarian and head colon can be prevented. Typically, at least about 10 percent is reduced from the risk of developing cancer in the subject who has a high risk factor. Another aspect of the present invention provides a method for reducing the risk of developing advanced premalignant dysphasia in a subject. |
priorityDate | 2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492675 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280427 |
Total number of triples: 17.